.jpg "Mary Ann A. Drosnock, MS, CIC, CFER, RM, FAPIC, AAMIF photo")
Director, Clinical Affairs
Healthmark Industries
Bath, Pennsylvania, United States
Mary Ann Drosnock is the Director of Clinical Affairs at Healthmark Industries, where she provides expertise on medical device reprocessing and infection prevention. Mary Ann also served as the past co-chair of AAMI Working Group 84, which writes ST91, the national standard on flexible endoscope reprocessing, and TIR 99 on probes and dilators' processing. Before joining Healthmark, Mary Ann managed the Infection Control Programs for Olympus America. She started her career as a pharmaceutical microbiologist and taught Microbiology courses at the college level.
Mary Ann has a B.S. in Biology from Albright College, and an M.S. in Quality/Regulatory Affairs from Temple University. Additionally, she has certifications in Drug Development, Pharmaceutical Science, Infection Control, and Flexible Endoscope Reprocessing. Mary Ann is a Nationally Certified Registered Microbiologist and a Fellow for APIC and AAMI. She is also currently in her final year of a Doctoral Program in Health Science.
Healthmark Industries (Employment)
Saturday, March 19, 2022
9:30 AM – 10:30 AM CDT
Friday, March 25, 2022